Evidence map›Paper›PMID 29555018›Full record

ArticleeLife2018

Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Laurelle Jackson, Jessica Hunter, Sandile Cele, Isabella Markham Ferreira, Andrew C Young, Farina Karim, Rajhmun Madansein, Kaylesh J Dullabh, Chih-Yuan Chen, Noel J Buckels and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Laurelle Jackson *Africa Health Research Institute, Durban, South Africa.
Jessica Hunter *Africa Health Research Institute, Durban, South Africa.
Sandile CeleAfrica Health Research Institute, Durban, South Africa.
Isabella Markham FerreiraAfrica Health Research Institute, Durban, South Africa.
Andrew C YoungAfrica Health Research Institute, Durban, South Africa.ORCID http://orcid.org/0000-0003-3616-7956
Farina KarimAfrica Health Research Institute, Durban, South Africa.
Rajhmun MadanseinDepartment of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa.
Kaylesh J DullabhDepartment of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa.
Chih-Yuan ChenDepartment of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa.
Noel J BuckelsDepartment of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa.
Yashica GangaAfrica Health Research Institute, Durban, South Africa.
Khadija KhanAfrica Health Research Institute, Durban, South Africa.
Mikael BoulleAfrica Health Research Institute, Durban, South Africa.
Gila LustigAfrica Health Research Institute, Durban, South Africa.
Richard A NeherBiozentrum, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-2525-1407
Alex SigalAfrica Health Research Institute, Durban, South Africa.ORCID http://orcid.org/0000-0001-8571-2004
Africa Health Research Institute · ZAUniversity of KwaZulu-Natal · ZACentre for the AIDS Programme of Research in South Africa · ZAHarvard University · USMax Planck Institute for Infection Biology · DESIB Swiss Institute of Bioinformatics · CH

Funding

Identification of the HIV Reservoir in Lymph Nodes Using Single Cell RNA-SeqR01AI138546 · NIAID · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SIGAL, ALEXANDER · 2018 to 2022
$721k
Ongoing HIV replication as a CNS persistence mechanism in the face of cARTR21MH104220 · NIMH · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SIGAL, ALEXANDER · 2014 to 2015
$297k
European Research Council Stg. 260686NIAID NIH HHS R01 AI138546NIH HHS R21MH104220NIMH NIH HHS R21 MH104220
6 · The paper itself

Abstract

HIV has been reported to be cytotoxic in vitro and in lymph node infection models. Using a computational approach, we found that partial inhibition of transmissions of multiple virions per cell could lead to increased numbers of live infected cells. If the number of viral DNA copies remains above one after inhibition, then eliminating the surplus viral copies reduces cell death. Using a cell line, we observed increased numbers of live infected cells when infection was partially inhibited with the antiretroviral efavirenz or neutralizing antibody. We then used efavirenz at concentrations reported in lymph nodes to inhibit lymph node infection by partially resistant HIV mutants. We observed more live infected lymph node cells, but with fewer HIV DNA copies per cell, relative to no drug. Hence, counterintuitively, limited attenuation of HIV transmission per cell may increase live infected cell numbers in environments where the force of infection is high.

Indexed as

AlgorithmsAlkynesBenzoxazinesCD4 Lymphocyte CountCD4-Positive T-LymphocytesCell DeathCell Line, TumorCells, CulturedCyclopropanesHIV-1HIV InfectionsHost-Pathogen InteractionsHumansLymph NodesModels, TheoreticalReverse Transcriptase InhibitorsAlkynesBenzoxazinesCyclopropanesefavirenzReverse Transcriptase Inhibitorscell-to-cell spreadcomputational biologyHIV induced cell deathhumaninfectious diseaseLymph nodemicrobiologymultiple Infections per cellsystems biologyviral fitnessvirus

Identifiers

PMID29555018
PMCPMC5896883
OpenAlexW2734499055

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.